December 2011. Walter Kolch, Director, Systems Biology Ireland & Conway Institute at University College Dublin describes SBI’s approach to systems biology in an exclusive interview with B2Bioworld. What is unique compared to Institutes at Seattle, Tokyo, Singapore, Luxembourg, or other where. What is the role of theory to guide experiments? Is there a non-trivial meaning of “perturbation” experiments? Which diseases are targeted, and which strategies are followed to answer those questions which AstraZeneca, Hewlett Packard, Pfizer, Servier, and other pharma and IT partners are eager to know beforehand.Reading time: 8 min
Read Now: |
B2Bioworld offers you background information
Rudi Balling, Director Luxembourg Centre for Systems Biomedicine,on system theory and pitfalls of loose concepts in using technologies
A systems look at DNA sequencing for personalized medicine by Leroy Hood, President Institute for Systems Biology, Seattle (US)
Christof von Kalle, at the time Head of Germany’s National Center for Tumor Diseases on new approaches to achieve tangible clinical results – or to manoeuvring into dead ends